Fundraising Fox

Inductive Bio

Brooklyn, US · Founded 2021 · Delaware corporation · 44 employees on LinkedIn · 11 known investors

Find your way into Inductive Bio

636 people in our graph share verified history with the Inductive Bio team — schools, employers, funds. One of them is your warm intro.

Crystal Huangunlockedknows Alexander Taylor · together at Harvard University (overlapped)
×7knows the team · via Harvard University
knows the team · via Inductive Bio
knows the team · via Massachusetts Institute of Technology
×2knows the team · via Constellation Pharma

Inductive Bio builds AI and machine learning software to accelerate drug discovery for pharmaceutical and biotech researchers, combining computational chemistry with expertise in translating complex drug programs from preclinical to clinical stages.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

Inductive Bio was founded in 2021 by Josh Haimson, Ben Birnbaum, and Alexander Taylor.

JHJosh Haimson
Josh HaimsoninCo-Founder and CEO
BBBen Birnbaum
Ben BirnbauminPh.D.
ATAlexander Taylor
Alexander TaylorinPh.D.Medicinal chemist who has led project and chemistry teams from screening through development candidate nomination, now working on Inductive Bio, which builds AI and machine learning software to accelerate drug discovery for pharmaceutical and biotech researchers.

Board

RGRohan Ganesh
Rohan GaneshinInvestor & Board DirectorPartner at Obvious Ventures

Investors · 11

AlleyCorpNew York · $1M – $5M
Andreessen HorowitzMenlo Park · $500K – $50M
Coalition OperatorsDover · $500K
Lux CapitalNew York · $100K – $100M
Obvious VenturesSan Francisco · $250K – $6Mvia Vishal Vasishth · led
Alley Robotics VenturesreportedCohasset · $500K – $2Mvia Abe Murray · inferred
Axial VCreportedSan Francisco · $100K – $5M
Bessemer Venture PartnersreportedRedwood City · $5M – $100M
Characterreported · 2 sourcesMilwaukee · $2M
Madrona Venture GroupreportedSeattle · $2M – $10M
S32reportedPalo Alto

Funding

SEC filings, press & company announcements

$25.1M disclosed across 1 of 2 rounds · 2023–2025

▶$25.1MraisedMay 2025 · 10 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Benjamin Edward BirnbaumExecutive Officer, Director
  • Joshua Daniel HaimsonExecutive Officer, Director
  • Rohan GaneshDirector
Offering amount
$25.1M
Amount sold
$25.1M
First sale
Mar 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Inductive Bio went on to found or lead other companies.

Ankit MahadeviaAdvisorFounded Spero TherapeuticsMark DePristoAdvisorFounded BigHat Biosciences

Competitors · 2

by search overlap
Recursion (NASDAQ: RXRX)25 shared keywordsRecursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments. The company combines life scientists and software engineers to solve problems at the intersection of biology and technology.
Numerion Labs15 shared keywordsNumerion combines drug discovery expertise with machine learning and computational chemistry. The company applies AI to drug development.

Companies competing with Inductive Bio for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Inductive Bio Raises $25M to Scale AI Platform for Predicting Drug Behavior Before Synthesisbiopharmatrend.com · May 2025Inductive Bio Raises $25M Series A to Transform Small Molecule Drug Discovery with Industry-Wide AI Platformprnewswire.com · May 2025Inductive Bio Raises $25M in Series A Fundingfinsmes.com · May 2025Inductive Bio Emerges from Stealth, Unveiling an ML Platform to Accelerate Compound Optimization in Drug Discovery - BioSpacebiospace.com · Dec 2023Inductive Bio Raises $4.3M in Seed Fundingfinsmes.com · Dec 2023

Frequently asked questions

What does Inductive Bio do?
Inductive Bio builds AI and machine learning software to accelerate drug discovery for pharmaceutical and biotech researchers, combining computational chemistry with expertise in translating complex drug programs from preclinical to clinical stages.
Who founded Inductive Bio?
Inductive Bio was founded by Josh Haimson, Ben Birnbaum, Alexander Taylor in 2021.
Who are Inductive Bio's investors?
Inductive Bio's investors include AlleyCorp, Andreessen Horowitz, Coalition Operators, Lux Capital, Obvious Ventures, Alley Robotics Ventures, Axial VC, Bessemer Venture Partners and 3 more.
How much funding has Inductive Bio raised?
Inductive Bio has disclosed $25.1M raised across 1 of its 2 known rounds.
Where is Inductive Bio headquartered?
Inductive Bio is headquartered in Brooklyn, US.